175 related articles for article (PubMed ID: 7075642)
21. Use of beta-adrenoceptor blocking drugs in hyperthyroidism.
Feely J; Peden N
Drugs; 1984 May; 27(5):425-46. PubMed ID: 6144501
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics and pharmacodynamics of propranolol stereoisomers in hyperthyroid patients.
Tawara K; Kawashima K; Ishikawa H; Yamamoto K; Saito K; Ebihara A; Yoshida S
Eur J Clin Pharmacol; 1981 Feb; 19(3):197-203. PubMed ID: 6894282
[TBL] [Abstract][Full Text] [Related]
23. Interactions of phenobarbital with propranolol in the dog. 2. Bioavailability, metabolism and pharmacokinetics.
Vu VT; Bai SA; Abramson FP
J Pharmacol Exp Ther; 1983 Jan; 224(1):55-61. PubMed ID: 6848749
[TBL] [Abstract][Full Text] [Related]
24. Sotalol: another beta adrenergic blocking agent?
Ahlquist RP
J Clin Pharmacol; 1979; 19(8-9 Pt 2):495-6. PubMed ID: 489768
[No Abstract] [Full Text] [Related]
25. Absence of changes in drug disposition and catecholamine sensitivity in the hyperthyroid dog.
Ishizaki T; Tawara K
Br J Pharmacol; 1980; 71(1):143-55. PubMed ID: 7470733
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics of propranolol during pregnancy.
O'Hare MF; Kinney CD; Murnaghan GA; McDevitt DG
Eur J Clin Pharmacol; 1984; 27(5):583-7. PubMed ID: 6519163
[TBL] [Abstract][Full Text] [Related]
27. Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.
Johnsson G; Regàrdh CG
Clin Pharmacokinet; 1976; 1(4):233-63. PubMed ID: 13958
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics of beta-receptor-blocking agents in relation to their anti-hypertensive effect.
Gugler R; Bodem G; Dengler HJ
Clin Sci Mol Med Suppl; 1976 Dec; 3():473s-475s. PubMed ID: 15758
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetic properties and bioavailability of methimazole.
Jansson R; Lindström B; Dahlberg PA
Clin Pharmacokinet; 1985; 10(5):443-50. PubMed ID: 4042519
[TBL] [Abstract][Full Text] [Related]
30. Propranolol and hyperthyroidism: sequential changes in serum iodothyronine (T4, T3, rT3) concentrations during therapy until clinical remission.
Pinho MO; Medeiros YS; Rosenthal D; Francalanci CC
Braz J Med Biol Res; 1983 Jul; 16(2):111-7. PubMed ID: 6652288
[TBL] [Abstract][Full Text] [Related]
31. Effect of oral charcoal and urine pH on sotalol pharmacokinetics.
Kärkkäinen S; Neuvonen PJ
Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):441-6. PubMed ID: 6092287
[TBL] [Abstract][Full Text] [Related]
32. Effect of food, food constituents and fluid volume on the bioavailability of sotalol.
Kahela P; Anttila M; Tikkanen R; Sundquist H
Acta Pharmacol Toxicol (Copenh); 1979 Jan; 44(1):7-12. PubMed ID: 367055
[TBL] [Abstract][Full Text] [Related]
33. Sotalol intoxication, two patients with concentration-effect relationships.
Neuvonen PJ; Elonen E; Tarssanen L
Acta Pharmacol Toxicol (Copenh); 1979 Jul; 45(1):52-7. PubMed ID: 474159
[TBL] [Abstract][Full Text] [Related]
34. Propranolol and hyperthyroidism: serum free fatty acids and glucose-induced insulin release in nondiabetic thyrotoxic patients during treatment to clinical compensation.
de Medeiros YS; Rosenthal D; Pinho MO; Francalanci CC
Metabolism; 1983 May; 32(5):518-23. PubMed ID: 6341765
[TBL] [Abstract][Full Text] [Related]
35. Studies on the pharmacokinetics and pharmacodynamics of the beta-adrenergic blocking agent sotalol in normal man.
Schnelle K; Klein G; Schinz A
J Clin Pharmacol; 1979; 19(8-9 Pt 2):516-22. PubMed ID: 489770
[TBL] [Abstract][Full Text] [Related]
36. No stereoselective first-pass hepatic extraction of propranolol.
Jackman GP; McLean AJ; Jennings GL; Bobik A
Clin Pharmacol Ther; 1981 Sep; 30(3):291-6. PubMed ID: 7273593
[TBL] [Abstract][Full Text] [Related]
37. Studies of the effect of thyroid dysfunction on the elimination of beta-adrenoreceptor blocking drugs.
Bell JM; Russell CJ; Nelson JK; Kelly JG; McDevitt DG
Br J Clin Pharmacol; 1977 Feb; 4(1):79-82. PubMed ID: 14661
[No Abstract] [Full Text] [Related]
38. [Absence of effect of propranolol on urinary excretion of 3-methylhistidine in hyperthyroidism].
Beylot M; Riou JP; Sautot G; Mornex R
Presse Med; 1984 Sep 1-8; 13(30):1829-31. PubMed ID: 6236442
[TBL] [Abstract][Full Text] [Related]
39. Acute and chronic effects of sotalol and propranolol on ventricular repolarization using constant-rate pacing.
Creamer JE; Nathan AW; Shennan A; Camm AJ
Am J Cardiol; 1986 May; 57(13):1092-6. PubMed ID: 3518383
[TBL] [Abstract][Full Text] [Related]
40. The effect of ageing on the hepatic clearance of propranolol.
Castleden CM; George CF
Br J Clin Pharmacol; 1979 Jan; 7(1):49-54. PubMed ID: 760742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
